- Bruker Corp has revised its full-year 2025 adjusted earnings per share (EPS) forecast to a range of $1.85 to $1.90, down from a previous forecast range of $1.95 to $2.05. The market had estimated an EPS of $1.93.
- For the third quarter, Bruker reported revenues of $860.5 million, surpassing the market estimation of $846.2 million.
- The company anticipates a decrease in non-GAAP EPS for fiscal year 2025, projecting $1.85 to $1.90, a significant drop from the $2.41 recorded in fiscal year 2024.
- The reduced earnings and revenue are attributed to diminished demand for academic and research instruments, particularly in the first half of 2025.
- The company attributed the lowered guidance to previous market weaknesses and EPS dilution due to a higher share count.
- Despite the reduction in EPS forecast, Bruker’s shares experienced a rise of 2.2% in pre-market trading, reaching $39.80, with 4,132 shares traded.
- Analyst recommendations include seven buys, six holds, and one sell.
A look at Bruker Corp Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 2 | |
| Growth | 2 | |
| Resilience | 2 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 2.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Analysts using the Smartkarma Smart Scores system have assessed Bruker Corp and provided ratings across different factors. The company received a moderate score of 3 for Value, indicating a fair valuation compared to its peers. However, its Dividend, Growth, Resilience, and Momentum scores all fall within the range of 2 to 3, suggesting room for improvement in these areas. Bruker Corp‘s diversified focus on life science systems, field analytical systems, and advanced materials research tools positions it in a stable but not overly compelling long-term outlook based on the Smart Scores assessment.
Bruker Corporation, known for designing and manufacturing proprietary life science systems and field analytical systems, demonstrates a strategic emphasis on spectrometry and X-ray technology platforms. With its measured scores across key factors like Value, Dividend, Growth, Resilience, and Momentum, Bruker Corp appears to have a solid foundation in place but may need to focus on enhancing areas like dividend potential, growth prospects, and market momentum to bolster its long-term prospects in the competitive landscape.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
